J B CHEMICALS PHARMACEUTICALS LTD Q3 RESULTS
Stock market update: Fertilisers stocks up as market falls
The 30-share BSE Sensex closed down 624.82 points at 81551.63
Stock market update: Nifty Pharma index advances 0.11%
The Nifty Pharma index closed 0.11 per cent up at 21524.95.
Stock market update: Fertilisers stocks up as market falls
The 30-share BSE Sensex closed down 624.82 points at 81551.63
Stock market update: Nifty Pharma index advances 0.11%
The Nifty Pharma index closed 0.11 per cent up at 21524.95.
Stock market update: Nifty Pharma index advances 0.08% in a weak market
The Nifty Pharma index was trading 0.08 per cent up at 21518.3.
IndusInd Bank shares in focus amid NFRA complaint over audit discrepancies
NFRA has received a complaint highlighting audit lapses tied to the bank’s forex derivatives. The irregularities, flagged internally, may have a financial impact of Rs 2,100 crore pre-tax. Regulatory bodies, including the RBI, SEBI, and ICAI, are scrutinising the matter. Meanwhile, key resignations have followed amid accounting gaps in the microlending business.
- Go To Page 1
MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%
Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the capital in hand, they may either expand into some other segment, or farm out the extra cash as a special dividend. These companies could thus become dividend plays. If the company increases its focus on India and does it through already listed entities, then there will be strong upward re-rating. But if the focus shifts to a 100% subsidiary, there will be strong de-rating and underperformance. These stocks are thus for investors who have a high risk appetite
Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 25% in 1 year
As the bulls try to make a comeback, keep a couple of things in mind if you are putting money in the stock market. First, buy quality stocks at dips and have a long-term perspective while doing so. Second, focus on the business you are going to own after you buy that stock. Buy the right business, even if it is expensive, and returns are assured over the long term. Our selected stocks for today depict a strong upward trajectory in their overall average score which is based on five key pillars: Earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
JM Financial retains Buy on Sun Pharma, lowers target price to Rs 2,025
JM Financial maintains a Buy call on Sun Pharmaceutical Industries, setting a revised target price of Rs 2025. Sun Pharma's Q4FY25 results showed an 8% YoY top-line growth, driven by India formulations and global specialty sales, despite a decline in US formulations. Future growth hinges on Ilumya's Phase 3 data, Leqselvi's launch, and the Checkpoint Therapeutics acquisition.
Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 27% in 1 year
Going with the assumption that the macro picture is turning bullish, it would be better to ignore phases of expected volatility. These will come and create panic in the short term. But things will get sorted out in the medium- to long-term. So, look for stocks with a long-term perspective and forget about the noise on the street. Our selected stocks for today depict a strong upward trajectory in their overall average score which is based on five key pillars: Earnings, fundamentals, relative valuation, risk, and price momentum. This implies that there has been a significant improvement in their market outlook in the given time frame.
7 Best Serums for Acne-Prone Skin in 2025
Finding the right skincare product for acne-prone skin can be overwhelming, particularly with the numerous options available on the market. This carefully curated list highlights the 7 best serums for acne-prone skin in 2025, featuring dermatologist-recommended formulas that fight breakouts, reduce scars, and improve skin texture. Backed by real user reviews and suited for various skin types, these picks are designed to help you achieve clearer, calmer and healthier skin.
Stock market update: Nifty Pharma index falls 0.41%
The Nifty Pharma index closed 0.41 per cent down at 21434.25.
Stock market update: Nifty Pharma index falls 0.41%
The Nifty Pharma index closed 0.41 per cent down at 21434.25.
Grasim Industries shares rise 3% after Q4 profit jumps 9% YoY
Grasim Industries shares: Revenue from operations rose by 17% year-on-year to Rs 44,267 crore, fueled by robust performance across the building materials, chemicals, and financial services segments. Additionally, the company’s board has proposed a dividend of Rs 10 per share for FY25.
Grasim Industries Q4 Results: Cons PAT rises 9% YoY to Rs 1,496 crore. Rs 10 per share dividend announced
Grasim Industries posted a 9% YoY rise in Q4FY25 net profit at ₹1,496 crore, with revenue growing 17% to ₹44,267 crore. The company declared a ₹10 dividend per share and reported strong sequential growth in both profit and topline.
Emcure Pharmaceuticals Q4 Results: Profit surges 63% YoY on strong domestic and international growth
Emcure Pharmaceuticals reported a 63% YoY rise in Q4 net profit to Rs 197 crore, driven by strong domestic and international growth. EBITDA rose 25.2%, with focus on margin improvement, product launches, and operational efficiency in FY26.
Stock market update: Nifty Pharma index falls 0.93%
The Nifty Pharma index closed 0.93 per cent down at 21521.75.
Stock market update: Nifty Pharma index falls 0.93%
The Nifty Pharma index closed 0.93 per cent down at 21521.75.
Stock market update: Nifty Pharma index advances 1.25%
The Nifty Pharma index closed 1.25 per cent up at 21723.65.
Stock market update: Nifty Pharma index advances 1.66% in an upbeat market
The Nifty Pharma index was trading 1.66 per cent up at 21812.85.
Stock market update: Nifty Pharma index advances 1.74% in an upbeat market
The Nifty Pharma index was trading 1.74 per cent up at 21830.45.
Stock market update: Nifty Pharma index falls 1.31%
The Nifty Pharma index closed 1.31 per cent down at 21456.15.
Stock market update: Nifty Pharma index falls 1.31%
The Nifty Pharma index closed 1.31 per cent down at 21456.15.
India Playbook 2025: Global Cheer, Local Resilience Amid Geopolitical Risks
Global equity markets have surged, fueled by eased trade tensions and a shift towards bilateral agreements. India's markets reflect improving macro fundamentals, including rebounding forex reserves and increased banking liquidity. Government capex revival and renewed FII inflows further bolster resilience. While consumption slowdown and geopolitical tensions pose challenges, sectors like auto and capital goods outperform.
Best Face Washes for all skin types to beat the heat in Summer 2025
Summer brings sweat, oil, and grime that can clog pores and cause breakouts. Here are top 8 face washes for all skin types—oily, dry, sensitive, and combination—that will keep your skin clean, balanced, and refreshed through summer of 2025. From gentle cleansers to deep purifiers, find the perfect face wash to match your skin needs this season.
Stock market update: Nifty Pharma index falls 0.11% in a weak market
The Nifty Pharma index was trading 0.11 per cent down at 21716.65.
Stock market update: Nifty Pharma index advances 1.25% in a weak market
The Nifty Pharma index was trading 1.25 per cent up at 21902.85.
Q4 results this week: ITC, Sun Pharma, IndusInd Bank, IndiGo, BEL among 81 companies set to announce earnings
India Inc's Q4 earnings season intensifies with 81 firms, including ITC, Sun Pharma, ONGC, and Hindalco, set to report this week, offering insights into sectoral performance and future growth outlooks.
Stock market update: Nifty Pharma index advances 0.57%
The Nifty Pharma index closed 0.57 per cent up at 21480.5.
Load More
